This filing is purely promotional with no new material information. Monitor future filings (e.g., Form S-4, proxy statement) for actual deal terms, shareholder vote dates, and regulatory updates that will drive the stock.
Price Chart
Executive Summary
ENDRA Life Sciences Inc. filed a Rule 425 prospectus in connection with its proposed business combination involving Renergen, Noble Africa, and ASP Isotopes. The filing announces a new investor website hosted at redchip.com/stocks/NDRA, launched on September 24, 2026, but contains no new financial data, deal terms, or material updates. This is a routine promotional communication with no actionable information for traders.
Key Financial Metrics
Key Facts
- Filing is a Rule 425 prospectus in connection with proposed transactions involving ENDRA, ASP Isotopes, Renergen, and Noble Africa.
- A new investor website was launched on September 24, 2026, hosted at https://www.redchip.com/stocks/NDRA.
- No new financial data, deal terms, or material updates are provided in this filing.
- The filing contains extensive forward-looking statements and risk factors but no concrete changes to the deal structure or timeline.
- Cross-filing context shows a prior 425 filed on September 9, 2026, also routine and promotional in nature.
Financial Impact
No financial figures disclosed in this filing.
Risk Factors
- Deal completion risk: conditions to closing may not be satisfied, including stockholder approval and regulatory approvals.
- Financing risk: Renergen's ability to obtain funding for Phase 2 of the Virginia Gas Project is uncertain.
- Nasdaq continued listing risk: ENDRA must maintain listing until deal closes, and the combined company must remain listed post-closing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001213900-26-103599 |
| Document: 0001213900-26-103599-index-headers.html | 0001213900-26-103599 |
| Document: 0001213900-26-103599-index.html | 0001213900-26-103599 |
| Document: 0001213900-26-103599.txt | 0001213900-26-103599 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 425 | $4.82 | awaiting T+5 | — | $4.96 (+2.93%) |
Oct 8, 2026 19d ago | 3 | $5.46 $4.74 | ▼ −13.19% | ▼ −11.22% | $4.96 (−9.14%) |
Oct 8, 2026 19d ago | SC 13D | $5.46 $4.74 | ▼ −13.19% | ▼ −11.22% | $4.96 (−9.14%) |
Oct 1, 2026 26d ago | 425 | $6.06 $5.46 | ▼ −9.90% | ▼ −11.06% | $4.96 (−18.14%) |
Oct 1, 2026 26d ago | 8-K | $6.06 $5.46 | ▼ −9.90% | ▼ −11.06% | $4.96 (−18.14%) |
Sep 25, 2026 4w ago | 425 | $5.80 $6.31 | ▲ +8.79% | ▲ +7.59% | $4.96 (−14.47%) |
Sep 9, 2026 6w ago | 425 | $5.83 $5.13 | ▼ −12.01% | ▼ −11.67% | $4.96 (−14.91%) |
Aug 17, 2026 10w ago | 8-K | $4.51 $4.75 | ▲ +5.32% | ▲ +5.52% | $4.96 (+10.00%) |
Jul 17, 2026 14w ago | 425 | $4.99 $5.23 | ▲ +4.81% | ▲ +5.50% | $4.96 (−0.58%) |
Jul 9, 2026 15w ago | 8-K | $5.49 $5.27 | ▼ −4.01% | ▼ −3.88% | $4.96 (−9.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers